See the latest UiPath Inc Class A stock price (PATH:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...